These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25748439)
21. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma. Wang Z; Cai H; Lin L; Tang M; Cai H Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409 [TBL] [Abstract][Full Text] [Related]
23. Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction. Sail V; Rizzo AA; Chatterjee N; Dash RC; Ozen Z; Walker GC; Korzhnev DM; Hadden MK ACS Chem Biol; 2017 Jul; 12(7):1903-1912. PubMed ID: 28541665 [TBL] [Abstract][Full Text] [Related]
24. Interleukin 10 gene -1082A/G polymorphism is associated with osteosarcoma risk and poor outcomes in the Chinese population. Cui Y; Zhu JJ; Ma CB; Cui K; Wang F; Ni SH; Zhang ZY Tumour Biol; 2016 Apr; 37(4):4517-22. PubMed ID: 26503210 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of X-Box Binding Protein 1 (XBP1) Correlates to Poor Prognosis and Up-Regulation of PI3K/mTOR in Human Osteosarcoma. Yang J; Cheng D; Zhou S; Zhu B; Hu T; Yang Q Int J Mol Sci; 2015 Dec; 16(12):28635-46. PubMed ID: 26633383 [TBL] [Abstract][Full Text] [Related]
26. Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma. Yang W; He M; Zhao J; Wang Z Med Oncol; 2014 Feb; 31(2):826. PubMed ID: 24381140 [TBL] [Abstract][Full Text] [Related]
27. Association between ERCC1 and ERCC2 gene polymorphisms and chemotherapy response and overall survival in osteosarcoma. Cao ZH; Yin HP; Jiang N; Yu B Genet Mol Res; 2015 Aug; 14(3):10145-51. PubMed ID: 26345951 [TBL] [Abstract][Full Text] [Related]
28. Effects of murine double minute 2 polymorphisms on the risk and survival of osteosarcoma: a systemic review and meta-analysis. Wang L; Liu Z; Jing P; Shao L; Chen L; He X; Gong W Tumour Biol; 2014 Feb; 35(2):1649-52. PubMed ID: 24122202 [TBL] [Abstract][Full Text] [Related]
29. Genetic variations in interleukin-6 polymorphism and the association with susceptibility and overall survival of osteosarcoma. Qi Y; Zhao C; Li H; Zhang B; Tada K; Abe H; Tada M Tumour Biol; 2016 Jul; 37(7):9807-11. PubMed ID: 26810186 [TBL] [Abstract][Full Text] [Related]
30. Genome sequencing analysis of blood cells identifies germline haplotypes strongly associated with drug resistance in osteosarcoma patients. Bhuvaneshwar K; Harris M; Gusev Y; Madhavan S; Iyer R; Vilboux T; Deeken J; Yang E; Shankar S BMC Cancer; 2019 Apr; 19(1):357. PubMed ID: 30991985 [TBL] [Abstract][Full Text] [Related]
31. TopBP1 promotes malignant progression and correlates with poor prognosis in osteosarcoma. Wu DP; Yan XB; Liu LG; Tian C; Han K; Zhang H; Min DL Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4022-4031. PubMed ID: 29028101 [TBL] [Abstract][Full Text] [Related]
32. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma. Qin Y; Ye J; Zhao F; Hu S; Wang S Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883 [TBL] [Abstract][Full Text] [Related]
33. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain. Pustovalova Y; Maciejewski MW; Korzhnev DM J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975 [TBL] [Abstract][Full Text] [Related]
34. Analysis of chemotherapy dosage and dosage intensity and survival outcomes of high-grade osteosarcoma patients younger than 40 years. Sun L; Li Y; Li H; Zhang J; Li B; Ye Z Clin Ther; 2014 Apr; 36(4):567-78. PubMed ID: 24636527 [TBL] [Abstract][Full Text] [Related]
35. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells. Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320 [TBL] [Abstract][Full Text] [Related]
36. Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population. Wang K; Zhao J; He M; Fowdur M; Jiang T; Luo S Tumour Biol; 2016 Jan; 37(1):1105-12. PubMed ID: 26276359 [TBL] [Abstract][Full Text] [Related]
37. COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death. He M; Wang Z; Zhao J; Chen Y; Wu Y Tumour Biol; 2014 Feb; 35(2):1297-305. PubMed ID: 24072491 [TBL] [Abstract][Full Text] [Related]
39. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Liu W; Zhao ZY; Shi L; Yuan WD Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657 [TBL] [Abstract][Full Text] [Related]
40. Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics. Engert F; Kovac M; Baumhoer D; Nathrath M; Fulda S Oncotarget; 2017 Jul; 8(30):48794-48806. PubMed ID: 27447864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]